» Articles » PMID: 38337595

Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

Abstract

. Oxidative stress has been involved in the pathogenesis of rheumatoid arthritis (RA). The serum malondialdehyde (MDA) level is a reliable biomarker of oxidative stress status. In the present work, we aimed to analyze how a comprehensive characterization of the disease characteristics in RA, including a lipid profile, insulin resistance, and subclinical atherosclerosis, relates to serum MDA levels. . In a cross-sectional study that included 430 RA patients, serum MDA levels were evaluated. Multivariable analysis was performed to examine the relationship of MDA with disease activity scores and disease characteristics, including subclinical carotid atherosclerosis, a comprehensive lipid molecule profile, and indices of insulin resistance and beta cell function indices. . The erythrocyte sedimentation rate (ESR) showed a significant and positive relationship with MDA. However, this did not occur for other acute phase reactants such as C-reactive protein or interleukin-6. Although the DAS28-ESR score (Disease Activity Score in 28 joints) had a positive and significant association with MDA serum levels, other disease activity scores that do not use the erythrocyte sedimentation rate in their formula did not show a significant relationship with MDA. Other disease characteristics, such as disease duration and the existence of rheumatoid factor and antibodies against citrullinated protein, were not related to serum MDA levels. This also occurred for lipid profiles, insulin resistance indices, and subclinical carotid atherosclerosis, for which no associations with circulating MDA were found. . The disease characteristics are not related to circulating MDA levels in patients with RA.

Citing Articles

Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease.

Merino de Paz N, Carrillo-Palau M, Hernandez-Camba A, Abreu-Gonzalez P, de Vera-Gonzalez A, Gonzalez-Delgado A Antioxidants (Basel). 2024; 13(10).

PMID: 39456425 PMC: 11505033. DOI: 10.3390/antiox13101171.


Circulating Malondialdehyde Is a Potential Biomarker for Predicting All-Cause Mortality during Follow-Up by Reflecting Comprehensive Inflammation at Diagnosis in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Chung J, Yoon T, Do H, Park Y, Lee S Medicina (Kaunas). 2024; 60(7).

PMID: 39064611 PMC: 11278744. DOI: 10.3390/medicina60071182.


New Clinical Markers of Oxidized Lipid-Associated Protein Damage in Children and Adolescents with Obesity.

Kostopoulou E, Varemmenou A, Kalaitzopoulou E, Papadea P, Skipitari M, Gil A Children (Basel). 2024; 11(3).

PMID: 38539349 PMC: 10969367. DOI: 10.3390/children11030314.

References
1.
Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D . Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem. 2005; 38(10):951-5. DOI: 10.1016/j.clinbiochem.2005.06.010. View

2.
Merino de Paz N, Garcia-Gonzalez M, Gomez-Bernal F, Quevedo-Abeledo J, de Vera-Gonzalez A, Lopez-Mejias R . Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus. Antioxidants (Basel). 2023; 12(8). PMC: 10451961. DOI: 10.3390/antiox12081535. View

3.
Landi M . Commentary to: "Improving the thiobarbituric acid-reactive-substances assay for estimating lipid peroxidation in plant tissues containing anthocyanin and other interfering compounds" by Hodges et al., Planta (1999) 207:604-611. Planta. 2017; 245(6):1067. DOI: 10.1007/s00425-017-2699-3. View

4.
Walter M, Jacob R, Jeffers B, Ghadanfar M, Preston G, Buch J . Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol. 2004; 44(10):1996-2002. DOI: 10.1016/j.jacc.2004.08.029. View

5.
Grinnell S, Yoshida K, Jasin H . Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite. Arthritis Rheum. 2005; 52(1):80-3. DOI: 10.1002/art.20760. View